Literature DB >> 16903958

Atrial fibrillation burden during the post-implant period after crt using device-based diagnostics.

Burkhard Hügl1, Hans-Jürgen Bruns, Christine Unterberg-Buchwald, Anett Grosse, Berthold Stegemann, Bernward Lauer, J Christoph Geller, Maurizio Gasparini.   

Abstract

UNLABELLED: AF Burden After CRT Implantation. AIMS: Cardiac resynchronization therapy (CRT) is increasingly used in congestive heart failure (CHF) patients (with cardiac dyssynchrony). In addition to delivering therapy, CRT devices offer a variety of diagnostic tools for continuous long-term monitoring of clinically relevant information (i.e., occurrence and duration of arrhythmia episodes). METHODS AND
RESULTS: Eighty-four patients with drug-refractory CHF in NYHA-class II-IV received a CRT device. The response to CRT was assessed by determining NYHA class at baseline and at 3 months follow-up. Atrial fibrillation (AF) burden (defined as time of AF per day) was continuously measured by the device. A significant gradual reduction of AF burden (from 9.88 +/- 12.61 to 4.20 +/- 9.24 [hours/day]) and number of patients experiencing AF episodes (from 26 to 13) were observed during CRT.
CONCLUSIONS: (1) Diagnostic features for long-term monitoring of physiological variables provide useful information on the state and course of AF and may improve disease management. (2) AF burden reduces over time during the first 3 months after CRT implantation.

Entities:  

Mesh:

Year:  2006        PMID: 16903958     DOI: 10.1111/j.1540-8167.2006.00482.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  13 in total

1.  Impact of chronic atrial fibrillation in patients with severe heart failure and indication for CRT: data of two registries with 711 patients (1999-2006 and 2007-6/2008).

Authors:  G Luedorff; R Grove; M Kowalski; E Wolff; J Thale; W Kranig
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2011-12

2.  Nonpharmacological Treatment of Atrial Fibrillation: What Is the Role of Device Therapy?

Authors:  Lucie Riedlbauchová; Václav Durdil; Jakub Honěk; Josef Veselka
Journal:  Int J Angiol       Date:  2020-04-28

Review 3.  Is cardiac resynchronization therapy an antiarrhythmic therapy for atrial fibrillation? A systematic review and meta-analysis.

Authors:  Paul L Hess; Kevin P Jackson; Vic Hasselblad; Sana M Al-Khatib
Journal:  Curr Cardiol Rep       Date:  2013-02       Impact factor: 2.931

4.  Feasibility and efficacy of electrical cardioversion after cardiac resynchronization implantation in patients with permanent atrial fibrillation.

Authors:  Pietro Turco; Antonio D'Onofrio; Giuseppe Stabile; Francesco Solimene; Vincenzo La Rocca; Filippo Vecchione; Assunta Iuliano; Natale Marrazzo; Stefano De Vivo; Ciro Cavallaro; Valter Bianchi; Alessia Agresta; Carmine Ciardiello; Antonio De Simone
Journal:  J Interv Card Electrophysiol       Date:  2012-08-14       Impact factor: 1.900

Review 5.  Resynchronization therapy in the context of atrial fibrillation: benefits and limitations.

Authors:  Uta C Hoppe
Journal:  J Interv Card Electrophysiol       Date:  2007-04-21       Impact factor: 1.900

6.  Effect of cardiac resynchronization therapy on conversion of persistent atrial fibrillation to sinus rhythm.

Authors:  Melanie Hauck; Alexander Bauer; Frederik Voss; Hugo A Katus; Ruediger Becker
Journal:  Clin Res Cardiol       Date:  2008-11-25       Impact factor: 5.460

Review 7.  Atrial fibrillation in heart failure: current treatment of patients with remodeled atria.

Authors:  Hans-Ruprecht Neuberger; Jan-Christian Reil; Oliver Adam; Ulrich Laufs; Christian Mewis; Michael Böhm
Journal:  Curr Heart Fail Rep       Date:  2008-12

8.  Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial Fibrillation: Findings From the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.

Authors:  Prateeti Khazanie; Melissa A Greiner; Sana M Al-Khatib; Jonathan P Piccini; Mintu P Turakhia; Paul D Varosy; Frederick A Masoudi; Lesley H Curtis; Adrian F Hernandez
Journal:  Circ Heart Fail       Date:  2016-06       Impact factor: 8.790

Review 9.  Atrial Fibrillation In Heart Failure: New Directions In Diagnosis, Risk Assessment And Risk Reduction.

Authors:  Richard J A Till; Martin R Cowie
Journal:  J Atr Fibrillation       Date:  2014-04-30

10.  Treatment of atrial fibrillation with a dual defibrillator in heart failure patients (TRADE HF): protocol for a randomized clinical trial.

Authors:  Giovanni Luca Botto; Giuseppe Boriani; Stefano Favale; Maurizio Landolina; Giulio Molon; Claudio Tondo; Mauro Biffi; Giuseppe Grandinetti; Paolo De Filippo; Giovanni Raciti; Luigi Padeletti
Journal:  Trials       Date:  2011-02-15       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.